Market Overview

Liver Cancer Therapeutics - World Markets, 2023: CAGR is Projected to Grow at 8% - ResearchAndMarkets.com

Share:

The "Global
Liver Cancer Therapeutics Market - Segmented by Therapy Area, End User,
and Geography - Growth, Trends, and Forecast (2018 - 2023)"

report has been added to ResearchAndMarkets.com's
offering.

The global liver cancer therapeutics market is expected to register a
CAGR of around 8% during the forecast period (2018-2023).

Rising Incidence of Cancer

Liver cancer incidence has been rising in the US since the mid-1970s,
and it is expected to continue to grow through till 2030. Change in the
current lifestyle of individuals has led to the exposure of a large
amount of population to the risk factors that contribute to liver
cancer. The risk factors include hepatitis (caused by either the
hepatitis B or hepatitis C virus), type 2 diabetes, metabolic disorders
& excess body weight, alcohol consumption, and tobacco smoking.

It has also been shown that liver cancer risk increases substantially
with the increase in one's body mass index (BMI). More than half of the
adult population in the US is overweight. Along with this high demand
for therapeutic drugs for liver cancer, this creates great opportunities
for manufacturers to produce more drugs and create a competitive
landscape.

Other Key Highlights

  • Stringent Regulatory Policies for Therapeutics
  • North America Dominates the Market

Major Development in the Market

  • Food and Drug Administration (FDA) granted accelerated approval to the
    immunotherapy drug nivolumab (Opdivo) for some patients with advanced
    liver cancer.

Companies Profiled

  • Alnylam Pharmaceuticals Inc.
  • Onyx Pharmaceuticals Inc.
  • F. Hoffmann-La Roche Ltd.
  • Pfizer Inc.
  • Arqule Inc.
  • Jennerex Biotherapeutics Inc.
  • Celsion Corp.
  • Bayer Schering Pharma AG
  • 4SC AG
  • Bristol-Myers Squibb Company

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/8gd3vh/liver_cancer?w=4

View Comments and Join the Discussion!